Menu
/REGISTER
Montecito
Tolman Wiker
Pac Premier
Fielding
Farmers merchants
Nixon Peabody
Express Pros
Loading...
You are here:  Home  >  Biotech  >  Current Article

Atara Biotherapeutics stock falls sharply after reporting big loss

By   /   Tuesday, February 26th, 2019  /   Comments Off on Atara Biotherapeutics stock falls sharply after reporting big loss

    Print       Email
Thousand Oaks biotech Atara Biotherapeutics announced an $80 million net loss, or $1.75 per share, in the fourth quarter of 2018, missing analyst estimates of $1.31 and sending shares tumbling 15 percent in early trading Feb. 26. The company reported a 151 percent increase in research and development costs to $62.3 million in the fourth…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

57 health care workers to be laid off in Simi Valley

Read More →